China Stroke Primary Prevention Trial

NCT00794885 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20702

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypertension

Interventions

DRUG: Enalapril/folic acid
DRUG: Enalapril maleate

Sponsor

Shenzhen Ausa Pharmed Co.,Ltd

Collaborators

[object Object]